Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's
Authors not listed
University of Wisconsin, Madison · 2009
Abstract
Angiotensin converting enzyme inhibitors (ACE-I) are a group of blood pressure-lowering medicines. Some studies suggest that ACE-I, such as ramipril, may help prevent Alzheimer's disease (AD). The purpose of the research is to see how ramipril affects a substance in the body called beta-amyloid. Beta-amyloid is found in the brain and in the liquid around the brain and spinal cord. High amounts of beta-amyloid may be associated with a greater risk of getting Alzheimer's disease. This study will see if ramipril can lower the amount of beta-amyloid in the spinal fluid. This study will also see if ramipril affects blood vessel function and memory and thinking. The investigators hope that future studies will show whether ramipril might prevent memory loss and decrease the chance of developing Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Anonymous. (2009). Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's. <em>University of Wisconsin, Madison</em>. https://clinicaltrials.gov/study/NCT00980785
Vancouver
Anonymous. Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's. University of Wisconsin, Madison. 2009.
BibTeX
@misc{anon2009Studyi,
title = {Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's},
author = {Anonymous},
journal = {University of Wisconsin, Madison},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Patrick Lao 2017
Open access · US-GOV
Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240
William Charles Kreisl 2016
Open access · US-GOV
Imaging Tau in Alzheimer's Disease and Normal Aging
National Institute on Aging (NIA) 2010
Open access · US-GOV
A Pilot Study of Exendin-4 in Alzheimer s Disease
University of California, Los Angeles 2000
Open access · US-GOV
Anti-Inflammation in AD: PET Imaging Supplement
National Institute of Neurological Disorders and Stroke (NINDS) 1999
Open access · US-GOV
Nefiracetam Therapy of Alzheimer's Type Dementia
University of Pittsburgh 2022
Open access · US-GOV